Magenta Therapeutics, Inc.·4

Feb 7, 4:18 PM ET

GARDNER JASON 4

4 · Magenta Therapeutics, Inc. · Filed Feb 7, 2019

Insider Transaction Report

Form 4
Period: 2019-02-05
GARDNER JASON
DirectorSee Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-02-05+182,900182,900 total
    Exercise: $7.13Exp: 2029-02-04Common Stock (182,900 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable in 12 equal quarterly installments beginning on January 1, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION